Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 6/20 | 0.45 |
| ▸ | RAB9A | P51151 | 6/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HRAS | P01112 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16352168 | 0.90 | NPC1 (0.42) | NPC1RAB9ATSHRHRASCETP | |
| SCHEMBL19853420 | 0.78 | ATM (0.52) | NPC1RAB9ATSHRHRASATM | |
| SCHEMBL1240611 | 0.76 | HRAS (0.46) | NPC1RAB9ATSHRHRASALDH1A1 | |
| SCHEMBL16352169 | 0.75 | CETP (0.43) | CETP | |
| SCHEMBL1829762 | 0.74 | NPC1 (0.50) | NPC1RAB9ATSHRHRASALDH1A1 | |
| SCHEMBL437919 | 0.74 | MAOA (0.48) | NPC1RAB9ATSHRHRAS | |
| SCHEMBL2700609 | 0.73 | MEN1 (0.59) | ALDH1A1ATM | |
| SCHEMBL9157683 | 0.72 | ALDH1A1 (0.52) | NPC1RAB9AHRASALDH1A1 | |
| Hydrochloric Acid SCHEMBL6436425 | 0.72 | GAA (0.50) | NPC1RAB9ATSHRHRASALDH1A1 | |
| SCHEMBL17805686 | 0.72 | HRAS (0.46) | NPC1RAB9ATSHRHRASALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9593136-B2 | Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase | THE GEORGE WASHINGTON UNIVERSITY (US) | 2017-03-14 | — | — | US | disclosed |
| US-20140378418-A1 | COMPOUNDS FOR INHIBITING 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2014-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140378418-A1 | COMPOUNDS FOR INHIBITING 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE | DCXR, G6PD, GRHPR | NPC1 4548/4885RAB9A 4182/4885TSHR 1505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.